Elevated CSN6 may be prognostic for poor survival colorectal cancer

the ONA take:

A study from The University of Texas MD Anderson Cancer Center identified a protein, CSN6, a subunit of a protein complex known as COP9 signalsome, that correlated with poor survival in patients with colorectal cancer. The researchers found that elevated CSN6 is a biomarker for worse recurrence-free survival in patients with colon cancer.

CSN6 is normally regulated through the EGFR and ERK signaling pathways. When overexpressed via ERK2 in particular, it leads to deregulation of beta-catenin, a transcription factor known to be linked to cancer development.

The current standard of treatment for colorectal cancer in patients at high risk of recurrent or metastatic disease includes surgery, chemotherapy, and targeted therapies.

The researchers report that defining the molecular alterations can help guide treatment and improve clinical care. 

Most cancer patients want tumor profiling, but have mixed feelings about other genetic information t
CSN6, a subunit of a protein complex known as COP9 signalsome, correlated with poor survival in patients with colorectal cancer.
A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center. The study revealed that CSN6, a subunit of a protein complex known as COP9 signalsome, is overexpressed in colorectal cancer tissue samples.
READ FULL ARTICLE From Medical Express
Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs